Pictured: Photo illustration of hundred dollar bill and graph/iStock, Darren415 Healthcare and technology-focused venture capital firm Canaan is adding $100 million in new capital to its biopharma investment funds, the company announced Wednesday.  The Menlo Park, Calif.-based firm’s injection of new funds will bring the company’s total amount raised since early 2023 to over $1 billion.